Latest News

The sector, which is currently valued at around USD 15 billion and expected to reach USD 50 billion by 2030, is addressing the country’s unique healthcare challenges while making strides on the global stage by providing cutting-edge medical devices.

Himanshu Baid Managing Director of Poly Medicure, highlighted India's growing medical device industry, spurred by regulations implemented in 2023. Exports have nearly doubled since 2021, with 3,000 companies now manufacturing in India. By 2030, exports are projected to reach $20 billion, driven by global companies establishing local production.

In his year-ender interaction with CNBC-TV18, Mr. Himanshu Baid, MD, Poly Medicure, shared his growth expectations for both the company and

On track to meet margin & growth guidance for FY25', says Himanshu Baid, MD of Poly Medicure. Tells Prashant Nair, Surabhi Upadhyay & Nigel D'Souza that they see 50% growth in renal biz in FY25. Adds higher tariffs in the US may not impact exports from India

India’s medical devices industry has grown tremendously over the years. The medical devices sector in India comprises large multinationals, small and midsized companies. India is the 4th largest Asian medical devices market after Japan, China, and South Korea, and among the top 20 medical devices markets globally.

Poly Medicure's efforts in cardiology and critical care will involve technological investments. Baid pointed out that these innovations are crucial for positioning Poly Medicure effectively in these sectors.

The medical technology sector in India is undergoing a transformative journey, set against the backdrop of a burgeoning health care landscape and increasing government focus on fostering innovation.

Business News | CNBC Awaaz brings to you latest business news, live share market updates, stock market updates, top business news in india, stock market updates, ipo latest updates, news updates on banking and financials, realty sector and it sector. Watch business news live, business news and share market live updates on CNBC Awaaz. Stay tune to get all the news of pre-opening trades, opening trades, and top calls in pehla sauda

Aim to do $15-20 m in terms of sales for the US in the next 3-5 years, says Himanshu Baid, MD, Poly Medicure. Tells Nigel D'Souza & Ekta Batra that Indian med tech sector will continue to remain robust in the next 5- 7 years

Aim to do $15-20 m in terms of sales for the US in the next 3-5 years, says Himanshu Baid, MD, Poly Medicure. Tells Nigel D'Souza & Ekta Batra that Indian med tech sector will continue to remain robust in the next 5- 7 years

NDTV Profit spoke to Mr Himanshu Baid, MD, Poly Medicure to discuss the company's future outlook. #growthplan #FutureOutlook #Polymed

The Indian medical device industry has experienced significant evolution over the past decade. From a nascent stage, we have grown into a robust and dynamic sector, offering a diverse range of cutting-edge products catering to both domestic and global markets. This growth is underpinned by factors such as a burgeoning healthcare landscape, increasing awareness, and a growing middle-class population demanding advanced healthcare solutions.

Artificial Intelligence stands at the forefront of innovation in MedTech, offering unprecedented capabilities in data analysis, pattern recognition, and decision-making. AI algorithms can sift through vast amounts of medical data with speed and accuracy, assisting healthcare providers in diagnosing diseases earlier and with greater precision than ever before.

Expect exports to grow at 25% & domestic biz growth of 20-22%, says Himanshu Baid, MD, Poly Medicure. Tells Ekta Batra & Mangalam Maloo that he expects overall growth of 22-24% in FY25

Himanshu Baid, Managing Director, Poly Medicure, looks to the government to introduce policies that foster a culture of innovation, including fresh incentives for research and development, and support for startups and innovators

यूरोप में आगे 25-30% तक ग्रोथ का अनुमान, इस साल घरेलू कारोबार में 23-25% तक ग्रोथ संभव: हिमांशु बैद, MD, Poly Medicure

यूरोप में आगे 25-30% तक ग्रोथ का अनुमान, इस साल घरेलू कारोबार में 23-25% तक ग्रोथ संभव: हिमांशु बैद, MD, Poly Medicure

Corporate View: Poly Medicure's Key Growth Levers, Domestic Demand & Exports & More. Healthy Growth Momentum To Sustain? Watch Himanshu Baid, MD, Poly Medicure Ltd.

Sticking to FY24 guidance for revenue at 20-22% growth & 25-27% for margin, says Himanshu Baid, MD, Poly Medicure. He tells Ekta Batra and Mangalam Maloo that he expects domestic business to grow 17-18% & export growth of 23% in Q4.

By enhancing R&D infrastructure and rationalising taxes, we can pave the way for the ambitious goal of achieving $50 billion by 2030. Access to capital is another key factor. We hope to witness financial incentives, support mechanisms, and innovative models that encourage investment in research, development, and manufacturing capabilities. .

As we stand on the cusp of a new fiscal year, we believe that the forthcoming budget holds immense promise for the healthcare industry, and we eagerly anticipate policies and provisions that will propel us to new heights. The government could consider enhancing budget allocation to 2.5% of the GDP, aiming to accelerate healthcare reforms & bolster infrastructure.

PolyMedicure posts a good set of Q2 numbers. MD, Himanshu Baid tells Sonia Shenoy, Ekta Batra & Mangalam Maloo that they have increased their revenue guidance from 20% to 22-24% for FY24.

PolyMedicure posts a good set of Q2 numbers. MD, Himanshu Baid tells Sonia Shenoy, Ekta Batra & Mangalam Maloo that they have increased their revenue guidance from 20% to 22-24% for FY24.

The introduction of this policy is a testament to the government's commitment to fostering innovation. India's healthcare system is rapidly evolving, and it represents a major step forward in realising our collective vision of accessible, high-quality healthcare for all.

#ZeeBusinessLive spoke with Mr. Himanshu Baid, MD, Polymed. He emphasized that #polymed will continue to invest in new technologies & innovations for better patient care. On guidance for FY24 #polymed targets EBITDA Margin of around 25%.

BQ Prime spoke with Mr. Himanshu Baid, MD, Polymed. He has highlighted that #polymed will be investing in new technologies and innovations for better patient care. On guidance for FY24 #polymed targets EBITDA Margin of around 25%.

Mr. Himanshu Baid, MD, Polymed, spoke with #etnow. He emphasises addition of new critical care vertical, expansion of manufacturing facilities, & Dial-Ezee 1st Made in India dialysis machine. Revenues to grow 20% in FY24

Mr. Himanshu Baid, MD, Polymed spoke to CNBC-TV18 highlighting domestic market grew over 30% & exports 25% as co reports strong Q1FY24 earnings. Similar margins expected in coming quarters.

India's Foremost Healthcare Magazine ~ IT Infra In Healthcare: In Need Of Systematic Approach

In an exclusive interview with Zee Business Mr. Himanshu Baid, Managing Director, Poly Medicure Ltd forecasts 20% growth with sustained margins.

CNBC-TV18 spoke to Mr. Himanshu Baid, MD, Polymed on guidance for FY24 wherein the company is targeting EBITDA Margin between 25-27%

CNBC TV18 spoke to Mr. Himanshu Baid, MD, Polymed, as Poly Medicure posted a strong Q4 as the margin recovered to a 6-qtr high. Expect domestic business to grow 20-22% in FY24.

CNBC TV 18 spoke to Mr. Himanshu Baid, MD, Polymed on the National Medical Devices Policy 2023, a game-changer for India's medtech sector in terms of streamlining regulatory processes fostering #EODB , adopting global standards, simulating the development of local manufacturing as well as improved competitiveness for the sector.

ETNOW SWADESH spoke to Mr. Himanshu Baid, MD, Polymed on guidance for FY 23-24 wherein the company is looking to target revenue growth of around 20%.

ETNOW spoke to Mr. Himanshu Baid, MD, Polymed on guidance for FY 23-24 wherein the company is looking to target revenue growth of around 20%

CNBC TV18 spoke to Mr Himanshu Baid , MD, Poly Medicure on the company's Q2 performance.

CNBC-TV18 speaks to Mr Himanshu Baid , MD, Poly Medicure to take his view on the impact of depreciation of the rupee. He also added that we're expecting exports to grow over 20%, and domestic biz by 25% in FY23.

Mr Himanshu Baid , Managing Director , Poly Medicure Ltd., and Ms Khushbu Sharma from VOICE OF HEALTHCARE connect over big concepts and ideas that have the potential to shift healthcare paradigms in the days ahead.

In an exclusive interview with ET Now Swadesh, Mr Himanshu Baid , MD, Poly Medicure Ltd. shared the roadmap for company's growth & expanding the global footprint.

India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

Mr. Himanshu Baid, MD, Poly Medicure shares Polymed's journey of 25 Years.

CNBC18 spoke to Mr. Himanshu Baid, MD, Polymed on guidance for FY 22-23 wherein the company is looking to target a revenue growth of around 18% to 20%.

Rural communities have long struggled to maintain access to quality healthcare services. Rural healthcare in India is characterised by a huge gap between supply and demand. The plight of rural hospitals has garnered particular attention from legislators, policymakers, and researchers in recent years. Currently,

ETNow Swadesh पर Poly Medicure Ltd. के Co-Founder & MD Himanshu Baid मौजूद रहे। उन्होने Ajay Sharma, Dimpy Kalra और Priyanak Uppal Anand के कंपनी से जुड़े सवालों के जवाब दिए। उन्बहोने बताया इस समय supply chain की वजह से import में बहुत समय लग रहा साथ ही crude के दामों की वजह से भी असर हुआ है।.

we scale up manufacturing at a global level, I think our products will become cost competitive and we will be able to then supply to almost every country in the world. Shahid Akhter, editor, ETHealthworld, spoke to Himanshu Baid, Director of Poly Medicure Limited, to know more about challenges and opportunities that can make the Govt’s vision of Atma Nirbhar Bharat a success story

Himanshu Baid, Chairman, NMTF, CII & Managing Director, Poly Medicure shares his expectations from budget 2022 for medical devices sector. Over the last few years, healthcare sector has received adequate attention in the Union Budgets. This year also, we anticipate that the government will introduce measures to improve the quality of healthcare and make it more affordable.

Medgate Today Top- 22 in Year 2022

Omicron Fears Spread | See increased costs due to supply chain disruption, says himanshupolymed, MD at Polymedicure. Price of plastic raw material has seen a rise of around 50%, he says

The role MedTech sector can play in improving the healthcare infrastructure of Tier 2 and Tier 3 cities.

We have shown to the world that PPE Kits, N95 masks, ventilators and many other critical equipments which we imported a year back are now being made in India.

We have shown to the world that PPE Kits, N95 masks, ventilators and many other critical equipments which we imported a year back are now being made in India.

Policy Medicure is one of the most added stocks by institutions in last 2 months. Himanshu Baid CMD of the company spoke with Ajaya Sharma about the business. MedTech sector was almost 90% dependent on imports till last year and that trend is now changing, he says.

When India was going through the pandemic’s second wave, many countries were able to send us ventilators, concentrators and many medical supplies. And from where did they send these supplies ? They sent them from their stockpile.

Mr. Himanshu Baid, Managing Director, PolyMedicure – Healthcare Leadership Reach Out Series

Himanshu Baid, the Managing Director at Poly Medicure, talks about their Q4 earnings and shares their Covid-19 portfolio. He says that Covid-19 products were not a big revenue growth leader for them, they only contributed to 2-3% of their revenue in FY21. But they surely picked up in April-May

The Indian industrv and medical devices comprises four segments consumables implants. diagnostic imaging. instruments & appliances and patient aids and, others. The current market size of the medical devices industrv India is estimated to be $11 bn.

Mar.04 — Himanshu Baid, managing director of New Delhi-based Poly Medicure Ltd., a medical-device maker, discusses the demand outlook for its products amid the Covid-19 pandemic and the company’s growth strategy. He speaks with Haslinda Amin and Rishaad Salamat during the “India

Indian Union Budget 2021-22: Budget 2021 is all about reviving the economy that got severely hit by the unprecedented pandemic. Considering that the budget was created in a difficult economic scenario, it is overall a good budget for the healthcare industry.

The COVID-19 pandemic presented us with unique conditions that has fast tracked innovation in the medical devices sector. The Indian government’s proactive approach to invite the participation of entrepreneurs, Indian and global medical devices companies in innovation and collaborations, has resulted in a host of new innovative solutions to help overcome the challenges posed by the pandemic.

The country is going through a big transformation. We are fortunate that the government of India has recognized MedTech as one of the champion sectors and this industry has a big wish list from this budget.

The country is going through a big transformation. We are fortunate that the government of India has recognized MedTech as one of the champion sectors and this industry has a big wish list from this budget.

The outbreak taught us the importance of local manufacturing, the domestic market and local supply chains. The COVID-19 pandemic presented India with unique conditions that forced the country to fast track innovations in the medical devices sector which, up until now, was highly dependent on imports.

People are now moving towards home healthcare and prevention : Himanshu Baid, Poly Medicure Ltd. Today customers are very well engaged on the digital platforms.

Himanshu Baid, Managing Director, Poly Medicure Ltd, talks about his expectations from the budget, PLI scheme, Atmanirbhar scheme, new plants at Faridabad & Jaipur and acquisition plans among others during a candid chat with Swati Khandelwal, Zee Business

A call for Atmanirbhar Bharat is just the right momentum for local manufacturing in a world dependent on imports. The Covid-19 pandemic situation was initially challenging in India with a dense population and highly import dependent Indian medical devices sector.

Zee Business speaks to our MD Mr. Himanshu Baid on Polymed’s journey & how the company is contributing to Govt.’s vision of Atmanirbhar Bharat.

By reskilling doctors and allied health professionals, especially in rural areas, India can create a much-needed robust healthcare infrastructure

Poly Medicure, a leading Indian manufacturer and exporter of medical devices, is planning to invest in newer technologies and is enhancing its R&D capabilities to deliver high quality medical devices at affordable prices.

This virtual event leveraged emerging and established digital technologies to engage participants in real-time, testament to the role digital transformation plays in the Medtech industry.

Himanshu Baid, MD, Poly Medicure suggests how India needs to re-strategise a long-term roadmap for promoting the medical devices industry in the post-pandemic era. He urges a stronger consistent approach and continued proactive efforts to create a more conducive environment for global and domestic manufacturing of medical devices.

We’ve seen the productivity has increased almost by 20% in last two months, that’s a big growth area for us.

Our productivity has increased due to sustained investments in automation: Himanshu Baid, Polymed

Healthcare Webinar Impact of COVID 19 on Indian Economy and Healthcare Sector by Mr Himanshu Baid

Zee Business spoke to Mr.Himanshu Baid, Managing Director on the COVID19 impact on healthcare sector.

Himanshu Baid is the Managing Director of Poly Medicure Limited (POLYMED). He holds an Engineering degree in Electronics & Communication and worked with Philips Communication Industries in Nuremberg, Germany.

Himanshu Baid is the Managing Director of Poly Medicure Limited (POLYMED). He holds an Engineering degree in Electronics & Communication and worked with Philips Communication Industries in Nuremberg, Germany.

MUMBAI: It’s not just critical medicines that could witness potential shortages due to the coronavirus outbreak. Commonly used medical devices like digital thermometers, infrared thermometers, nebulizers, blood pressure monitors and glucometers could face the same risk soon.